|
|
Funding Friday 02/19/2021 Edition 21
----- Office of Sponsored Programs -----
|
|
Please forward and share with other faculty who may be interested. |
|
The Office of Sponsored Programs will be the submitting authorized official for these announcements. We strongly encourage Principal Investigators to utilize the UNLV Corporate & Foundation Relations assistance with the preparation of any narrative portions of the proposal(s).
|
|
The Massage Therapy Association Invites Applications for Research Awards Grants. Letters of Intent Due: March 1, 2021 at 2:00pm PT. Ranging from $30,000 to $300,000 over three years.
Awarded in support of independent, high-quality research that contributes directly to the knowledge of massage therapy and/or its applications.
|
|
The Foundation for Prader-Willi Research Invites Research Applications Grants. Letters of Intent due March 5, 2021 2:00 pm PT. Up to $100,000.
Awarded for research that advances the understanding and treatment of Prader-Willi syndrome, with a possibility of a second year of funding upon competitive review.
|
|
The Melanoma Research Foundation Issues RFP for Translational Immuno-Oncology Research
Applications due March 15, 2021 at 2:00 pm PT. Up to $150,000 per year over two years ($300,000 total).
Awarded to a young investigator team in support of continuing melanoma research focused on immuno-oncology while fostering institutional cross-collaborations.
|
|
We spend money on programs we know improve health, like housing, nutrition, financial assistance, education, child care, or legal aid. But the financial benefits of these often flow elsewhere, in reduced costs for medical care from diseases and injuries prevented. Can better collaboration help balance this out-and help halt the inequities baked into the current system?
RWJF's Systems for Action program seeks proposals to measure the impact of collaborations across medical, social, and public health systems that allow organizations to better share in the costs, benefits, power and influence that govern these initiatives. Grants, up to $500,000 each, are available for research to evaluate solutions to these persistent problems.
|
|
Request for Proposals (RFP) Early Identification and Diagnosis of Axial Spondyloarthritis
Projects that will be considered for Pfizer support will focus on:
- Improving disease awareness and closing knowledge gaps in early identification and referral of patients with axial spondyloarthritis; specifically targeting non-rheumatologists and other Health Care Practitioners (HCPs)
- Increasing the understanding of the pathophysiology and epidemiology of axial spondyloarthritis, including risk factors and the spectrum of disease
|
|
Request for Proposals (RFP) BRAF-Mutant Melanoma: Treatment Selection and Side Effect Management
Projects that will be considered for Pfizer support will focus on:
- Increasing understanding of clinical data to inform treatment selection for patients with BRAF-mutant melanoma, and
- Increasing understanding of treatment side effects and how they can be managed by providers involved in the care of patients with BRAF-mutant melanoma
|
|
NIH Support for Conferences and Scientific Meetings: PA-21-151 Learn More
To support high quality scientific conferences that are relevant to the NIH's mission and to the public health.
|
|
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care: PA-21-164 Learn More
Research projects that test promising digital healthcare interventions aimed at improving quality of care and healthcare services delivery at the point of care.
|
|
High-End Instrumentation (HEI) Grant Program: PAR-21-126 Application Due: June 01, 2021. Learn More
The High-End Instrumentation (HEI) Grant program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems. The minimum award is $600,001. There is no maximum price limit for the instrument; however, the maximum award is $2,000,000. Instruments supported include, but are not limited to, biomedical imagers, high throughput robotic screening systems, X-ray diffractometers, mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, and cell sorters.
|
|
Shared Instrumentation Grant (SIG) Program: PAR-21-127 Application Due: June 01, 2021. Learn More
The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-priced, specialized, commercially available instruments or integrated instrumentation system. The minimum award is $50,000. There is no maximum price limit for the instrument; however, the maximum award is $600,000. Instruments supported include, but are not limited to: X-ray diffractometers, mass spectrometers, nuclear magnetic resonance spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.
|
|
Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV): RFA-AI-21-006 Application Due: July 13, 2021. Learn More
The purpose of this funding opportunity announcement is to solicit applications to expand basic research on non-polio enteroviruses (NPEV) that will inform the development of pan-enterovirus vaccines and broad-spectrum antivirals against enteroviruses A, B, C, and D.
|
|
|
|
|
|
|
